Advertisement

U.S. markets closed

S&P Futures
3,983.50
+5.50(+0.14%)
Dow Futures
32,355.00
+36.00(+0.11%)
Nasdaq Futures
12,862.00
+8.00(+0.06%)
Russell 2000 Futures
1,739.20
+6.70(+0.39%)
Crude Oil
69.54
-0.42(-0.60%)
Gold
1,994.40
-1.50(-0.08%)

Advertisement

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Visitors trend2W10W9M

129.39

-4.29

(-3.21%)

At close: 04:00PM EDT

129.39

0.00

(0.00%)

After hours:

07:44PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	133.68
Open	134.90
Bid	129.10 x 800
Ask	133.26 x 800
Day's Range	128.00 - 135.90
52 Week Range	117.08 - 189.07
Volume	833,319
Avg. Volume	679,476

Market Cap	31.401B
Beta (5Y Monthly)	0.24
PE Ratio (TTM)	2.97
EPS (TTM)	43.54
Earnings Date	Mar 27, 2023
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	Jun 02, 2022
1y Target Est	216.39

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

20% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BNTX

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

BioNTech SE
Analyst Report: BioNTech SEBioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
Rating
Fair Value
Economic Moat
3 months agoMorningstar